Tempus AI, Inc. (NASDAQ: TEM) is a Healthcare company (Medical - Healthcare Information Services) with a market capitalization of $11.5B. The Maz Rating grades it against the other companies in its sector.
Tempus AI, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $64.76, Tempus AI, Inc. trades at 7.6x sales and 23.5x book value. Over the last twelve months it generated about $1.5B of revenue and a net loss of $186M. It runs a gross margin of 64.5%, an operating margin of -18.5% and a net margin of -12.5%. It shows return on equity of -40.9%, return on invested capital of -13.4% and a free cash flow yield of -1.3%. On the balance sheet: a debt-to-equity ratio of 2.86 and a current ratio of 2.61. Over the past 52 weeks the share price ranged from $40.77 to $89.09, with a beta of 3.61.
Tempus AI, Inc. does not currently pay a dividend.
17 Wall Street analyst ratings cover the stock: 11 Buy and 6 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.